Cargando…

Manual of percutaneous coronary interventions : a step-by-step approach /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Brilakis, Emmanouil S. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London, United Kingdom : Academic Press, [2021]
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Front Cover
  • Manual of Percutaneous Coronary Interventions
  • Copyright Page
  • Dedication
  • Contents
  • List of contributors
  • PCI cases online links
  • CTO PCI cases online links
  • Introduction
  • Reference
  • A. The steps
  • 1 Planning
  • 1.1 Planning
  • 1.2 Monitoring
  • 1.3 Pharmacology
  • 1.4 Access
  • 1.5 Engagement
  • 1.6 Angiography
  • 1.7 Determine target lesion(s)
  • 1.8 Wiring
  • 1.9 Lesion preparation
  • 1.10 Stenting
  • 1.11 Access closure
  • 1.12 Physiology
  • 1.13 Imaging
  • 1.14 Hemodynamic support
  • References
  • 2 Monitoring
  • 2.1 Patient
  • 2.2 Electrocardiogram
  • 2.3. Pressure waveform
  • 2.4 Oxygen saturation
  • 2.5 Radiation dose-X-ray system and shield positioning
  • 2.6 Contrast volume
  • 2.7 Access site
  • 2.8 Medication administration (anticoagulation-ACT, sedation, other medications)
  • 2.9 Operator and t3 eam performance
  • 2.10 Cath lab environment
  • 2.11 Sterile field and equipment
  • 2.12 Equipment position within the body
  • 3 Medications
  • 3.1 Sedatives and analgesics
  • 3.1.1 Goals
  • 3.1.2 How?
  • 3.1.3 What can go wrong?
  • 3.1.3.1 Respiratory failure-hypopnea
  • 3.1.3.2 Delayed response to oral P2Y12 inhibitors which may lead to thrombotic complications
  • 3.2 Vasodilators
  • 3.2.1 Nitroglycerin
  • 3.2.1.1 Goals
  • 3.2.1.2 How?
  • 3.2.1.3 What can go wrong?
  • 3.2.1.3.1 Hypotension
  • 3.2.1.3.2 Headache, flushing, dizziness
  • 3.2.1.3.3 Tachycardia
  • 3.2.2 Nicardipine
  • 3.2.2.1 Goals
  • 3.2.2.2 How?
  • 3.2.2.3 What can go wrong?
  • 3.2.2.3.1 Hypotension
  • 3.2.3 Nitroprusside
  • 3.2.3.1 Goals
  • 3.2.3.2 How?
  • 3.2.3.3 What can go wrong?
  • 3.2.3.3.1 Hypotension
  • 3.2.4 Verapamil
  • 3.2.4.1 Goals
  • 3.2.4.2 How?
  • 3.2.4.3 What can go wrong?
  • 3.2.4.3.1 Hypotension
  • 3.2.5 Adenosine
  • 3.2.5.1 Goals
  • 3.2.5.2 How?
  • 3.2.5.3 What can go wrong?
  • 3.2.5.3.1 Heart block
  • 3.2.5.3.2 Atrial fibrillation
  • 3.2.5.3.3 Ventricular fibrillation
  • 3.3 Contrast media
  • 3.3.1 Goals
  • 3.3.2 How?
  • 3.3.3 What can go wrong?
  • 3.3.3.1 Contrast-induced acute kidney injury
  • 3.3.3.2 Allergic reactions
  • 3.3.3.3 Thyroid dysfunction
  • 3.4 Anticoagulants
  • 3.4.1 Goals
  • 3.4.2 How?
  • 3.4.2.1 Unfractionated heparin
  • 3.4.2.1.1 Dose
  • 3.4.2.1.2 Monitoring
  • 3.4.2.1.3 Reversal
  • 3.4.2.2 Bivalirudin
  • 3.4.2.2.1 Dose
  • 3.4.2.2.2 Monitoring
  • 3.4.2.2.3 Reversal
  • 3.4.3 Challenges
  • 3.4.3.1 ACT is low after anticoagulant administration
  • 3.4.4 What can go wrong?
  • 3.4.4.1 Bleeding
  • 3.4.4.2 Thrombosis
  • 3.4.4.3 Heparin-induced thrombocytopenia (HIT)
  • 3.5 Antiplatelet agents
  • 3.5.1 Dual antiplatelet therapy
  • 3.5.1.1 Goals
  • 3.5.1.2 How?
  • 3.5.1.2.1 Medication type
  • 3.5.1.2.2 Dose
  • 3.5.1.2.3 Pretreatment
  • 3.5.1.2.4 Switching between oral P2Y12 inhibitors
  • 3.5.1.2.5 DAPT duration
  • 3.5.1.3 What can go wrong?
  • 3.5.1.3.1 Bleeding
  • 3.5.1.3.2 Dyspnea
  • 3.5.1.3.3 Allergic reactions